Pharmacoeconomic Analysis of Cost Comparison Between Calcium Channel Blocker (CCB) and Angiotensin II Receptor Blocker (ARB) Antihypertensive Drugs in Hospitalized Hypertensive Patients at RSU Royal Prima. JURNAL FARMASIMED (JFM), [S. l.], v. 8, n. 2, p. 1146–1155, 2026. DOI: 10.35451/y2fhvc35. Disponível em: https://ejournal.medistra.ac.id/index.php/JFM/article/view/3371. Acesso em: 6 may. 2026.